COST Action Cancer nanomedicine - from the bench to the bedside (NANO2CLINIC) CA17140

Datos básicos

Código:

EU19/01

Dotación:

642,44 €

Año Inicial:

2019

Año final:

2023

Objetivos del proyecto

The objectives in Nano2Clinic are to: (1) promote and to foster active and multidisciplinary collaborations between industry and academia on each aspect of the design, development, and translation of cancer nanomedical agents, (2) foster synergies between complementary EU groups of excellence, thereby expanding the network beyond existing collaborations between Action partners, with particular attention to the strong, active involvement of SMEs, regulatory agencies, academic clinical research centers, clinical research organizations, and other public/industrial entities, (3) promote cross-pollination of competencies and transferring results within the EU actors belonging to public and privates sectors by extensive exchange of PhD students, young researchers and senior scientists, meetings and workshops, and collaborative scientific publications and patents and (4) disseminate results to all potential stakeholders, including public organisms, funding agencies, patients associations and the general public to increase EU citizen awareness of the social benefits of the Action results.

Unidades de investigación

• NANOMEDICINA

  

  Investigador Responsable

  Mónica López Fanarraga

  monica.lopez@unican.es